These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 17461317
1. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery. Kuitunen A, Suojaranta-Ylinen R, Kukkonen S, Niemi T. Scand J Surg; 2007; 96(1):72-8. PubMed ID: 17461317 [Abstract] [Full Text] [Related]
2. Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Niemi T, Schramko A, Kuitunen A, Kukkonen S, Suojaranta-Ylinen R. Scand J Surg; 2008; 97(3):259-65. PubMed ID: 18812277 [Abstract] [Full Text] [Related]
5. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Boldt J, Heesen M, Müller M, Pabsdorf M, Hempelmann G. Anesth Analg; 1996 Aug; 83(2):254-61. PubMed ID: 8694302 [Abstract] [Full Text] [Related]
9. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S, Kettler D. Br J Anaesth; 1997 Jan; 78(1):44-50. PubMed ID: 9059203 [Abstract] [Full Text] [Related]
10. Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution. Mortelmans YJ, Vermaut G, Verbruggen AM, Arnout JM, Vermylen J, Van Aken H, Mortelmans LA. Anesth Analg; 1995 Dec; 81(6):1235-42. PubMed ID: 7486110 [Abstract] [Full Text] [Related]
12. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Vogt NH, Bothner U, Lerch G, Lindner KH, Georgieff M. Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303 [Abstract] [Full Text] [Related]
13. Volume therapy in the critically ill: is there a difference? Boldt J, Müller M, Mentges D, Papsdorf M, Hempelmann G. Intensive Care Med; 1998 Jan; 24(1):28-36. PubMed ID: 9503219 [Abstract] [Full Text] [Related]
15. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, Paep R, Rodrigus I, Daper A, Trenchant A. Anesth Analg; 2005 Sep; 101(3):629-634. PubMed ID: 16115963 [Abstract] [Full Text] [Related]
16. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis. Van der Linden P, Dumoulin M, Van Lerberghe C, Torres CS, Willems A, Faraoni D. Crit Care; 2015 Mar 17; 19(1):87. PubMed ID: 25886765 [Abstract] [Full Text] [Related]
18. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. Allison KP, Gosling P, Jones S, Pallister I, Porter KM. J Trauma; 1999 Dec 17; 47(6):1114-21. PubMed ID: 10608543 [Abstract] [Full Text] [Related]
19. Albumin utilization in cardiac surgery after transition to hydroxyethyl starch 130/0.4. Romerill DB, Toyoda AY, Brodeur BE, Moellentin D. J Pharm Pract; 2012 Dec 17; 25(6):606-10. PubMed ID: 22797837 [Abstract] [Full Text] [Related]